% | $
Quotes you view appear here for quick access.

Aegerion Pharmaceuticals, Inc. (AEGR) Message Board

  • yassen_gregorivich yassen_gregorivich Nov 18, 2013 1:39 PM Flag

    400% growth rate expected 2013 to 2014

    According to what Yahoo Earnings Estimates report across the analysts.
    2013 = $50M
    2014 = $200M

    That is 400% year over year growth!!! Plus they will likely beat that anyway.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Growth in EPS is an excellent multiplier.

    • That is revenue, not earnings. The top will come quite quickly and the discovery of new patients then much more slowly. Then there will be no place to go. No pediatric patients unless a big study is done. No FCS patients either. I hope people really did read what I posted this weekend. I played your little game and let you post numbers, but no logic on the big picture. If I were Mr. Beer I'd look into juxtapid being used in HepC patients as their only alternative.....seriously, there could be some utilization there in stopping the formation of HepC viral particles. Good luck over the next two years might need it. t

      • 1 Reply to jetmanbash
      • What I gave was the best case scenario, that doesn't assume someone dying on the drug or any untoward allergic reaction or side-effect. When Omniflox came it was supposed to be the strongest antibiotic ever. And maybe it was, but after about 30K patients got treated with it things started to pop up and before you knew it, it was off the market. With only 23 patients and Mr. Beer taking the high profile if something goes wrong it will be that much more magnified.....sometimes the meek really do inherit the earth. t

1.74Aug 24 4:00 PMEDT